Nadroparin Calcium Injection
Formulation (FDF) · Injection · 0.4ml:4100AXaIU; 0.6ml:6150AXaIU
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Nadroparin Calcium Injection
- Dosage Form
- Injection
- Strength
- 0.4ml:4100AXaIU; 0.6ml:6150AXaIU
- Therapy Area
- Cardiovascular
- Indication
- Venous thromboembolism prophylaxis; Deep vein thrombosis; Unstable angina; Non-Q-wave myocardial infarction; Hemodialysis
- Current Status
- Official FDF licensing catalog (UB004)
- GMP Certification
- CN - NMPA; EU - EMA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price